Compare PCRX & COUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PCRX | COUR |
|---|---|---|
| Founded | 2006 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 932.9M |
| IPO Year | 2010 | 2021 |
| Metric | PCRX | COUR |
|---|---|---|
| Price | $23.50 | $5.32 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 15 |
| Target Price | ★ $30.25 | $10.53 |
| AVG Volume (30 Days) | 516.5K | ★ 6.6M |
| Earning Date | 04-30-2026 | 04-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 107.44 | 39.22 |
| EPS | ★ 0.07 | N/A |
| Revenue | $541,533,000.00 | ★ $757,500,000.00 |
| Revenue This Year | $6.78 | $9.43 |
| Revenue Next Year | $8.54 | $6.40 |
| P/E Ratio | $336.29 | ★ N/A |
| Revenue Growth | ★ 26.04 | 9.04 |
| 52 Week Low | $18.80 | $5.00 |
| 52 Week High | $27.64 | $13.56 |
| Indicator | PCRX | COUR |
|---|---|---|
| Relative Strength Index (RSI) | 49.85 | 44.26 |
| Support Level | $22.13 | $5.09 |
| Resistance Level | $24.20 | $6.41 |
| Average True Range (ATR) | 1.02 | 0.31 |
| MACD | -0.06 | -0.05 |
| Stochastic Oscillator | 42.93 | 22.62 |
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
Coursera Inc is an online learning platform that connects learners, educators, and institutions with the goal of providing educational content that is affordable, accessible, and relevant. It combines content, data, and technology into a single, unified platform that is customizable and extensible to both individual learners and institutions. The company operates through two reporting segments: Consumer and Enterprise. The majority of revenue is generated from the Consumer segment. The consumer segment targets individual learners seeking to obtain hands-on learning, gain valuable job skills, receive professional-level certifications, and otherwise increase their knowledge to start or advance their careers.